Table 2 Angiographic and procedural characteristics.
Hypertension | P | No-hypertension | P | |||
---|---|---|---|---|---|---|
HCY ≥ 15 µmol/L n = 202 | HCY < 15 µmol/L n = 157 | HCY ≥ 15 µmol/L n = 153 | HCY < 15 µmol/L n = 136 | |||
Diseased vessels | ||||||
LM | 21 (10.4%) | 14 (8.9%) | 0.639 | 12 (7.8%) | 8 (5.9%) | 0.512 |
LAD | 64 (31.7%) | 40 (25.5%) | 0.199 | 44 (28.8%) | 32 (23.5%) | 0.314 |
LCX | 48 (23.8%) | 40 (25.5%) | 0.708 | 39 (25.5%) | 24 (17.6%) | 0.107 |
RCA | 56 (27.7%) | 37 (23.6%) | 0.373 | 28 (18.3%) | 21 (15.4%) | 0.518 |
Multi-vessel disease | 124 (61.4%) | 75 (47.8%) | 0.010 | 77 (50.3%) | 54 (39.7%) | 0.005 |
NCCLs clogging | 30 (14.9%) | 12 (7.6%) | 0.035 | 15 (9.8%) | 6 (4.4%) | 0.419 |
IABP use | 17 (8.4%) | 5 (3.2%) | 0.040 | 7 (4.6%) | 2 (1.5%) | 0.239 |